Freebird Partners LP 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 2:14 pm Purchase | 2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 414,102 9.900% | 71,656 (+20.92%) | Filing |
| 2025-01-28 5:31 pm Purchase | 2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 342,446 9.990% | 272,214 (+387.59%) | Filing |
| 2023-07-20 7:52 pm Purchase | 2023-07-14 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 70,232 19.990% | 23,732 (+51.04%) | Filing |
| 2023-04-04 5:14 pm Purchase | 2023-04-03 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 46,501 12.600% | 28,329 (+155.89%) | Filing |
| 2022-12-02 5:01 pm Purchase | 2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 18,172 5.300% | 18,172 (New Position) | Filing |